These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 15740778

  • 1. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice.
    Akhisaroglu M, Kurtuncu M, Manev H, Uz T.
    Pharmacol Biochem Behav; 2005 Mar; 80(3):371-7. PubMed ID: 15740778
    [Abstract] [Full Text] [Related]

  • 2. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS.
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [Abstract] [Full Text] [Related]

  • 3. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice.
    Tammimäki A, Pietilä K, Raattamaa H, Ahtee L.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):118-25. PubMed ID: 16442094
    [Abstract] [Full Text] [Related]

  • 4. Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice.
    Hofford RS, Wellman PJ, Eitan S.
    J Psychopharmacol; 2012 Oct 15; 26(10):1355-65. PubMed ID: 22522973
    [Abstract] [Full Text] [Related]

  • 5. Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze.
    Vorhees CV, Johnson HL, Burns LN, Williams MT.
    Neurotoxicol Teratol; 2009 Oct 15; 31(1):1-10. PubMed ID: 18930132
    [Abstract] [Full Text] [Related]

  • 6. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
    Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K.
    Neuropharmacology; 2008 Apr 15; 54(5):815-23. PubMed ID: 18262573
    [Abstract] [Full Text] [Related]

  • 7. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M, Dekeyne A, Papp M, Millan MJ.
    Behav Pharmacol; 2006 Nov 15; 17(7):559-72. PubMed ID: 17021388
    [Abstract] [Full Text] [Related]

  • 8. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST, Baella SA, Stuebner NM, Crawford CA, McDougall SA.
    Brain Res; 2006 Feb 16; 1073-1074():269-75. PubMed ID: 16427034
    [Abstract] [Full Text] [Related]

  • 9. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
    Qin ZH, Zhou LW, Zhang SP, Wang Y, Weiss B.
    Mol Pharmacol; 1995 Oct 16; 48(4):730-7. PubMed ID: 7476901
    [Abstract] [Full Text] [Related]

  • 10. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul 16; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 11. Effect of methamphetamine on cognition and repetitive motor behavior of mice deficient for dopamine D2 and D3 receptors.
    Glickstein SB, Schmauss C.
    Ann N Y Acad Sci; 2004 Oct 16; 1025():110-8. PubMed ID: 15542707
    [Abstract] [Full Text] [Related]

  • 12. Reduced basal and ethanol stimulation of striatal extracellular dopamine concentrations in dopamine D2 receptor knockout mice.
    Job MO, Ramachandra V, Anders S, Low MJ, Gonzales RA.
    Synapse; 2006 Aug 16; 60(2):158-64. PubMed ID: 16715495
    [Abstract] [Full Text] [Related]

  • 13. Accumbal dopamine D2 receptor function is associated with individual variability in ethanol behavioral sensitization.
    Abrahao KP, Quadros IM, Andrade AL, Souza-Formigoni ML.
    Neuropharmacology; 2012 Feb 16; 62(2):882-9. PubMed ID: 21964435
    [Abstract] [Full Text] [Related]

  • 14. Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging.
    Ireland MD, Lowe AS, Reavill C, James MF, Leslie RA, Williams SC.
    Neuroscience; 2005 Feb 16; 133(1):315-26. PubMed ID: 15893653
    [Abstract] [Full Text] [Related]

  • 15. Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors.
    Rogóz Z, Wróbel A, Dlaboga D, Dziedzicka-Wasylewska M.
    Pol J Pharmacol; 2002 Feb 16; 54(4):381-9. PubMed ID: 12523492
    [Abstract] [Full Text] [Related]

  • 16. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J, Dougherty JJ, Nichols RA.
    J Neurochem; 2006 Jul 16; 98(2):481-94. PubMed ID: 16805841
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice.
    Barwatt JW, Hofford RS, Emery MA, Bates ML, Wellman PJ, Eitan S.
    Drug Alcohol Depend; 2013 Oct 01; 132(3):420-6. PubMed ID: 23932842
    [Abstract] [Full Text] [Related]

  • 18. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
    Gorriti MA, Ferrer B, del Arco I, Bermúdez-Silva FJ, de Diego Y, Fernandez-Espejo E, Navarro M, Rodríguez de Fonseca F.
    Pharmacol Biochem Behav; 2005 May 01; 81(1):71-7. PubMed ID: 15894066
    [Abstract] [Full Text] [Related]

  • 19. Behavioral profile of quinpirole in agonistic encounters between male mice.
    Navarro JF, Maldonado E.
    Methods Find Exp Clin Pharmacol; 1999 Sep 01; 21(7):477-80. PubMed ID: 10544391
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.
    Truong JG, Newman AH, Hanson GR, Fleckenstein AE.
    Eur J Pharmacol; 2004 Nov 03; 504(1-2):27-32. PubMed ID: 15507217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.